vs
Cooper Companies (The)(COO)与先锋自然资源公司(PR)财务数据对比。点击上方公司名可切换其他公司
先锋自然资源公司的季度营收约是Cooper Companies (The)的1.1倍($1.2B vs $1.1B),先锋自然资源公司净利率更高(29.0% vs 7.9%,领先21.1%),Cooper Companies (The)同比增速更快(4.6% vs -9.8%),过去两年Cooper Companies (The)的营收复合增速更高(6.9% vs -3.0%)
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业,旗下设有两大业务单元:主营隐形眼镜生产的库博光学,以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
先锋自然资源公司总部位于美国得克萨斯州欧文市,主要从事油气勘探业务,运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块,是该区域最大的土地权益持有方,2024年5月被埃克森美孚收购。
COO vs PR — 直观对比
营收规模更大
PR
是对方的1.1倍
$1.1B
营收增速更快
COO
高出14.4%
-9.8%
净利率更高
PR
高出21.1%
7.9%
两年增速更快
COO
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $84.6M | $339.5M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 23.1% |
| 净利率 | 7.9% | 29.0% |
| 营收同比 | 4.6% | -9.8% |
| 净利润同比 | -28.0% | 56.7% |
| 每股收益(稀释后) | $0.42 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
COO
PR
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $964.7M | $1.4B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.0B | $1.2B | ||
| Q2 24 | $942.6M | $1.2B | ||
| Q1 24 | $931.6M | $1.2B |
净利润
COO
PR
| Q4 25 | $84.6M | $339.5M | ||
| Q3 25 | $98.3M | $59.2M | ||
| Q2 25 | $87.7M | $207.1M | ||
| Q1 25 | $104.3M | $329.3M | ||
| Q4 24 | $117.5M | $216.7M | ||
| Q3 24 | $104.7M | $386.4M | ||
| Q2 24 | $88.9M | $235.1M | ||
| Q1 24 | $81.2M | $146.6M |
毛利率
COO
PR
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
营业利润率
COO
PR
| Q4 25 | 13.2% | 23.1% | ||
| Q3 25 | 16.6% | 29.6% | ||
| Q2 25 | 18.4% | 24.8% | ||
| Q1 25 | 18.9% | 36.6% | ||
| Q4 24 | 19.5% | 32.8% | ||
| Q3 24 | 19.2% | 32.5% | ||
| Q2 24 | 17.2% | 36.5% | ||
| Q1 24 | 16.4% | 37.7% |
净利率
COO
PR
| Q4 25 | 7.9% | 29.0% | ||
| Q3 25 | 9.3% | 4.5% | ||
| Q2 25 | 8.7% | 17.3% | ||
| Q1 25 | 10.8% | 23.9% | ||
| Q4 24 | 11.5% | 16.7% | ||
| Q3 24 | 10.4% | 31.8% | ||
| Q2 24 | 9.4% | 18.9% | ||
| Q1 24 | 8.7% | 11.8% |
每股收益(稀释后)
COO
PR
| Q4 25 | $0.42 | $0.48 | ||
| Q3 25 | $0.49 | $0.08 | ||
| Q2 25 | $0.44 | $0.28 | ||
| Q1 25 | $0.52 | $0.44 | ||
| Q4 24 | $0.59 | $0.31 | ||
| Q3 24 | $0.52 | $0.53 | ||
| Q2 24 | $0.44 | $0.36 | ||
| Q1 24 | $0.41 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $153.7M |
| 总债务越低越好 | $2.5B | $3.5B |
| 股东权益账面价值 | $8.2B | $10.3B |
| 总资产 | $12.4B | $17.9B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.34× |
8季度趋势,按日历期对齐
现金及短期投资
COO
PR
| Q4 25 | $110.6M | $153.7M | ||
| Q3 25 | $124.9M | $111.8M | ||
| Q2 25 | $116.2M | $451.0M | ||
| Q1 25 | $100.9M | $702.2M | ||
| Q4 24 | $107.6M | $479.3M | ||
| Q3 24 | $109.7M | $272.0M | ||
| Q2 24 | $112.4M | $47.8M | ||
| Q1 24 | $135.2M | $12.7M |
总债务
COO
PR
| Q4 25 | $2.5B | $3.5B | ||
| Q3 25 | $2.4B | $3.5B | ||
| Q2 25 | $2.5B | $4.0B | ||
| Q1 25 | $2.5B | $4.0B | ||
| Q4 24 | $2.6B | $4.2B | ||
| Q3 24 | $2.6B | $4.2B | ||
| Q2 24 | $2.7B | $3.9B | ||
| Q1 24 | $2.7B | $3.9B |
股东权益
COO
PR
| Q4 25 | $8.2B | $10.3B | ||
| Q3 25 | $8.4B | $10.0B | ||
| Q2 25 | $8.3B | $9.5B | ||
| Q1 25 | $8.1B | $9.4B | ||
| Q4 24 | $8.1B | $9.1B | ||
| Q3 24 | $7.9B | $9.0B | ||
| Q2 24 | $7.8B | $8.3B | ||
| Q1 24 | $7.7B | $7.0B |
总资产
COO
PR
| Q4 25 | $12.4B | $17.9B | ||
| Q3 25 | $12.4B | $17.3B | ||
| Q2 25 | $12.4B | $17.5B | ||
| Q1 25 | $12.2B | $17.1B | ||
| Q4 24 | $12.3B | $16.9B | ||
| Q3 24 | $12.1B | $16.6B | ||
| Q2 24 | $12.0B | $15.4B | ||
| Q1 24 | $12.0B | $15.1B |
负债/权益比
COO
PR
| Q4 25 | 0.30× | 0.34× | ||
| Q3 25 | 0.29× | 0.35× | ||
| Q2 25 | 0.30× | 0.42× | ||
| Q1 25 | 0.31× | 0.43× | ||
| Q4 24 | 0.32× | 0.46× | ||
| Q3 24 | 0.33× | 0.47× | ||
| Q2 24 | 0.34× | 0.46× | ||
| Q1 24 | 0.35× | 0.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $247.9M | $904.3M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | 2.66× |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势,按日历期对齐
经营现金流
COO
PR
| Q4 25 | $247.9M | $904.3M | ||
| Q3 25 | $261.4M | $766.5M | ||
| Q2 25 | $96.2M | $1.0B | ||
| Q1 25 | $190.6M | $898.0M | ||
| Q4 24 | $268.1M | $871.6M | ||
| Q3 24 | $207.5M | $954.4M | ||
| Q2 24 | $111.0M | $938.4M | ||
| Q1 24 | $122.7M | $647.6M |
自由现金流
COO
PR
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $36.9M | — | ||
| Q1 24 | $4.6M | — |
自由现金流率
COO
PR
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 0.5% | — |
资本支出强度
COO
PR
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 12.7% | — |
现金转化率
COO
PR
| Q4 25 | 2.93× | 2.66× | ||
| Q3 25 | 2.66× | 12.94× | ||
| Q2 25 | 1.10× | 5.01× | ||
| Q1 25 | 1.83× | 2.73× | ||
| Q4 24 | 2.28× | 4.02× | ||
| Q3 24 | 1.98× | 2.47× | ||
| Q2 24 | 1.25× | 3.99× | ||
| Q1 24 | 1.51× | 4.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |